ICAIDM · Registering as Listener

International Conference on Advances in Infectious Disease Medicine

16th Sep – 17th Sep 2026 Bekasi, Indonesia Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

!
Registration Closed
The registration deadline has ended. Participation is no longer available for this conference.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICAIDM
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Advances in Infectious Disease Medicine conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This session will explore the latest advancements in treatment protocols for various infectious diseases. Emphasis will be placed on evidence-based approaches and their clinical applicability.

This track will focus on the identification and management of emerging infectious diseases. Discussions will include global surveillance strategies and response mechanisms.

This session will delve into recent breakthroughs in vaccine research and development. Participants will examine the efficacy of new vaccines against prevalent infectious diseases.

This track will highlight the importance of multidisciplinary collaboration in the management of infectious diseases. Case studies will illustrate successful integrative strategies in clinical practice.

This session will address the design and implementation of clinical trials for infectious diseases. Ethical considerations and regulatory frameworks will also be discussed.

This track will focus on the importance of pharmacovigilance in monitoring the safety and efficacy of therapeutics for infectious diseases. Participants will learn about best practices and regulatory requirements.

This session will explore innovative patient care strategies tailored to individuals with infectious diseases. Emphasis will be placed on personalized medicine and patient-centered approaches.

This track will review the development and implementation of clinical guidelines for the treatment of infectious diseases. Participants will discuss the impact of guidelines on clinical outcomes.

This session will cover advanced techniques in disease monitoring and surveillance for infectious diseases. The role of technology and data analytics in enhancing public health responses will be emphasized.

This track will focus on the challenges and strategies in drug development aimed at combating antimicrobial resistance. Discussions will include novel therapeutic approaches and research initiatives.

This session will provide a global perspective on infectious diseases and their impact on public health. Participants will discuss international collaborations and policy implications.

COPYRIGHT © 2026 International Conference on Advances in Infectious Disease Medicine. ALL RIGHTS RESERVED